Liminatus Pharma selects Synex to advance CAR-T trial
Executive Overview In a significant milestone for the field of hematological oncology and cellular immunotherapy, Liminatus Pharma has officially engaged...
Archive
Tag: trial
Milestone’s etripamil nasal spray enters Phase III trial for atrial fibrillation
Executive Overview In a significant milestone for cardiovascular therapeutics, Milestone Pharmaceuticals has officially announced the dosing of the first patient...
AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology
Executive Overview The landscape of immuno-oncology has long been defined by the pursuit of combination therapies and multi-targeted biologic agents...
The Oral GLP-1 Frontier: Phase II Trial Shows Aleniglipron Delivers Up to 12% Weight Loss in Adults with Obesity
Executive Overview The landscape of obesity pharmacotherapy is undergoing a seismic shift. For years, the gold standard in incretin-based therapeutics...
Combating Type 2 Diabetes: How a Supercharged Mediterranean Lifestyle Cut Risk by 31% in Europe’s Largest Nutrition Trial
The classical Mediterranean diet has long held a golden reputation in nutritional science, widely celebrated for its robust heart and...
Akeso Doses First Patient in Landmark Phase II Trial Evaluating Novel AK146D1 and Ivonescimab Combination for Advanced Breast Cancer
Executive Overview In a significant milestone for next-generation oncology drug development, biopharmaceutical innovator Akeso has announced the successful dosing of...
Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity
Executive Overview In a significant milestone for metabolic therapeutics, biopharmaceutical innovator Neurocrine Biosciences has officially commenced a Phase I clinical...
Rethinking the Sweet Tooth: Six-Month Clinical Trial Challenges Global Public Health Dogma on Dietary Sweetness
Executive Overview For decades, modern nutritional science and global health authorities—including the World Health Organization (WHO)—have issued a unified warning:...
Summit Therapeutics Expands Global Oncology Footprint with Phase II/III HARMONi-GU1 Trial of Ivonescimab in Advanced Urothelial Carcinoma
Executive Overview In a significant strategic expansion of its oncology clinical development pipeline, Summit Therapeutics has announced the initiation of...
Advancing Immunotherapy Frontiers: Dispatch Bio Doses First Patient in Phase I Trial of DISP-10 for Advanced Gastrointestinal Cancers
Executive Overview In a significant milestone for modern oncology and the evolution of cell-based immunotherapies, clinical-stage biopharmaceutical company Dispatch Bio...
BioVie’s Stock Plummets 33% Following SUNRISE-PD Phase IIb Trial Data Release Utilizing Novel, Company-Created EPNIC-15 Endpoint
Executive Overview In the high-stakes world of biopharmaceutical research, the line separating scientific innovation from investor skepticism is razor-thin. On...
Unlocking the Gut-Pain Axis: Clinical Trial Reveals Daily Prebiotic Fiber Significantly Reduces Knee Osteoarthritis Symptoms
Executive Overview Knee osteoarthritis (OA) remains one of the most pervasive and debilitating conditions facing aging populations globally, affecting hundreds...
